chlorogenic acidWhat was measured
Measured, with no finding
707 endpoints
Show what was measuredHide what was measured
homocysteine concentrations
no effect
Quercetin-3-rutinoside did not significantly affect homocysteine concentrations.
PMID 11237928 · one of two readings recorded this
plasma total homocysteine 4-5 h after supplement intake (non-fasting sample)
increases, 12% (1.2 micromol/L; 95% CI: 0.6, 1.7) higher after chlorogenic acid than after placebo
Not recorded as a finding: same node, CAT:outcome/plasma-total-homocysteine, recorded once on the fasting sample its definition names; this is the post-dose sample, which the abstract does not call fasting
Total homocysteine in plasma collected 4-5 h after supplement intake was 12% (1.2 micromol/L; 95% CI: 0.6, 1.7) higher after chlorogenic acid and 11% (1.1 micromol/L; 95% CI: 0.6, 1.5) higher after black tea than after placebo.
PMID 11237928 · one of two readings recorded this
plasma total homocysteine 4-5 h after supplement intake (non-fasting)
increases, 12% (1.2 micromol/L; 95% CI: 0.6, 1.7) higher after chlorogenic acid than after placebo
Not recorded as a finding: CAT:outcome/plasma-total-homocysteine is defined on fasting plasma (or after a methionine load); this sample was drawn 4-5 h after the supplement, neither fasting nor after a methionine load. The fasting 20 h sample was claimed instead.
Total homocysteine in plasma collected 4-5 h after supplement intake was 12% (1.2 micromol/L; 95% CI: 0.6, 1.7) higher after chlorogenic acid and 11% (1.1 micromol/L; 95% CI: 0.6, 1.5) higher after black tea than after placebo.
PMID 11237928 · one of two readings recorded this
plasma total homocysteine (fasting plasma)
increases
Total homocysteine in fasting plasma collected 20 h after supplement intake was 4% (0.4 micromol/L; 95% CI: 0.0, 0.8) higher after chlorogenic acid and 5% (0.5 micromol/L; 95% CI: 0.0, 0.9) higher after black tea than after placebo.
PMID 11237928 · one of two readings recorded this
plasma total homocysteine (fasting plasma)
increases
Total homocysteine in fasting plasma collected 20 h after supplement intake was 4% (0.4 micromol/L; 95% CI: 0.0, 0.8) higher after chlorogenic acid and 5% (0.5 micromol/L; 95% CI: 0.0, 0.9) higher after black tea than after placebo.
PMID 11237928 · one of two readings recorded this
plasma total homocysteine (plasma collected after supplement intake, non-fasting)
increases
Total homocysteine in plasma collected 4-5 h after supplement intake was 12% (1.2 micromol/L; 95% CI: 0.6, 1.7) higher after chlorogenic acid and 11% (1.1 micromol/L; 95% CI: 0.6, 1.5) higher after black tea than after placebo.
PMID 11237928 · one of two readings recorded this
plasma total homocysteine (plasma collected after supplement intake, non-fasting)
increases
Total homocysteine in plasma collected 4-5 h after supplement intake was 12% (1.2 micromol/L; 95% CI: 0.6, 1.7) higher after chlorogenic acid and 11% (1.1 micromol/L; 95% CI: 0.6, 1.5) higher after black tea than after placebo.
PMID 11237928 · one of two readings recorded this
glucose metabolism in animal studies (cited, narrated); type 2 diabetes risk and glucose tolerance with coffee consumption (narrated, not pooled)
Not recorded as a finding: a review that discusses its trials without pooling them
Coffee is a source of several compounds that improved glucose metabolism in animal studies, including the chlorogenic acids and lignans.
PMID 16399494 · one of two readings recorded this
glucose metabolism
increases
Coffee is a source of several compounds that improved glucose metabolism in animal studies, including the chlorogenic acids and lignans.
PMID 16399494 · one of two readings recorded this
glucose metabolism
increases
Coffee is a source of several compounds that improved glucose metabolism in animal studies, including the chlorogenic acids and lignans.
PMID 16399494 · one of two readings recorded this
glucose tolerance
increases
Coffee consumption has been associated with improved glucose tolerance and a lower risk of type 2 diabetes in diverse populations in the U.S., Europe, and Japan.
PMID 16399494 · one of two readings recorded this
risk of type 2 diabetes
decreases
Coffee consumption has been associated with improved glucose tolerance and a lower risk of type 2 diabetes in diverse populations in the U.S., Europe, and Japan.
PMID 16399494 · one of two readings recorded this
risk of type 2 diabetes
decreases
The finding that higher consumption of decaffeinated coffee was associated with a lower risk of type 2 diabetes suggests that coffee constituents other than caffeine play a role.
PMID 16399494 · one of two readings recorded this
endothelial function (measure not named in the abstract)
no effect, p = 0.6
Not recorded as a finding: The sentence never names chlorogenic acid (agentless), and the abstract does not name the measure, so CAT:outcome/flow-mediated-dilation (brachial FMD by ultrasound) cannot be matched.
Markers of nitric oxide status (P > 0.10) and the measure of endothelial function (P = 0.60) were not significantly influenced.
PMID 22900702 · both readings recorded this
endothelial function
no effect, p = 0.6
Markers of nitric oxide status (P > 0.10) and the measure of endothelial function (P = 0.60) were not significantly influenced.
PMID 22900702 · one of two readings recorded this
markers of nitric oxide status, analytes not named in the abstract
no effect
Not recorded as a finding: the sentence is agentless and does not name the compound (rule 1), and the abstract names no analyte, so CAT:outcome/plasma-nitrate or CAT:outcome/plasma-nitrite cannot be chosen; P > 0.10 is a bound, not a value
Markers of nitric oxide status (P > 0.10) and the measure of endothelial function (P = 0.60) were not significantly influenced.
PMID 22900702 · one of two readings recorded this
markers of nitric oxide status (markers not named in the abstract)
no effect
Not recorded as a finding: The sentence never names chlorogenic acid (agentless), and the abstract does not name the markers, so CAT:outcome/plasma-nitrate and CAT:outcome/plasma-nitrite cannot be matched. P > 0.10 is a bound, not recorded as a value.
Markers of nitric oxide status (P > 0.10) and the measure of endothelial function (P = 0.60) were not significantly influenced.
PMID 22900702 · one of two readings recorded this
markers of nitric oxide status
no effect, p = 0.1
Markers of nitric oxide status (P > 0.10) and the measure of endothelial function (P = 0.60) were not significantly influenced.
PMID 22900702 · one of two readings recorded this
plasma chlorogenic acid concentration after dosing
increases
Not recorded as a finding: The subject's own plasma level after dosing. No outcome node for it; not an interaction with a second substance (exposure lane), and plasma is not a tissue (localisation lane).
Chlorogenic acid resulted in significantly higher plasma concentrations of chlorogenic acid (P < 0.001).
PMID 22900702 · one of two readings recorded this
plasma chlorogenic acid concentration
increases
Not recorded as a finding: the subject's own plasma level; no outcome node, and plasma is not a tissue for the localisation lane; P < 0.001 is a bound, not a value
Chlorogenic acid resulted in significantly higher plasma concentrations of chlorogenic acid (P < 0.001).
PMID 22900702 · one of two readings recorded this
plasma chlorogenic acid concentration
increases, p = 0.001
Chlorogenic acid resulted in significantly higher plasma concentrations of chlorogenic acid (P < 0.001).
PMID 22900702 · one of two readings recorded this
post-treatment diastolic blood pressure
decreases, p = 0.04
Relative to control, the mean post-treatment systolic blood pressure (-2.41 mmHg, 95% CI: -0.03, -4.78; P = 0.05) and diastolic blood pressure (-1.53 mmHg, 95% CI: -0.05, -3.01; P = 0.04) were significantly lower with chlorogenic acid.
PMID 22900702 · one of two readings recorded this
post-treatment systolic blood pressure
decreases, p = 0.05
Relative to control, the mean post-treatment systolic blood pressure (-2.41 mmHg, 95% CI: -0.03, -4.78; P = 0.05) and diastolic blood pressure (-1.53 mmHg, 95% CI: -0.05, -3.01; P = 0.04) were significantly lower with chlorogenic acid.
PMID 22900702 · one of two readings recorded this
Bond-Lader Alert (post-test)
p = 0.02
However, for post-test Alert scores a significant treatment effect was revealed (F(2,59)=4.18,p=.02).
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
increases, p = 0.07
At 120 minutes Alertness was found to be significantly greater with the green blend coffee in comparison to CGA (t=2.86, p=.02, d=0.52) and there was also a trend towards Alertness being greater with the green blend coffee in comparison to placebo (t=-2.16, p=.07, d=0.39).
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
increases, p = 0.02
Differences of Least Square Means revealed that Alertness was significantly greater with decaffeinated green blendcoffee in comparison to CGA overall (t=2.89, p=.02, d=0.53).
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
increases, p = 0.02
At 120 minutes Alertness was found to be significantly greater with the green blend coffee in comparison to CGA (t=2.86, p=.02, d=0.52)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
increases, p = 0.06
At 40 minutes there was a trend towards Alertness being greater with decaffeinated green blend coffee in comparison to CGA (t=2.41, p=.06, d=0.44).
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
n = 60
CGA | 60 | 66.29 (2.35) | 59.95 (2.59) | 57.09 (2.61)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
n = 60
CGA | 60 | 66.29 (2.35) | 59.95 (2.59) | 57.09 (2.61)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
n = 60
(POST) | Green Blend | 60 | 63.48 (2.53) | 61.49 (2.60) | 59.51 (2.72)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
n = 60
(POST) | Green Blend | 60 | 63.48 (2.53) | 61.49 (2.60) | 59.51 (2.72)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
n = 60
Bond-Lader Alert | Placebo | 60 | 64.06 (2.48) | 59.90 (2.75) | 56.76 (2.64)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (post-test)
n = 60
Bond-Lader Alert | Placebo | 60 | 64.06 (2.48) | 59.90 (2.75) | 56.76 (2.64)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (pre-test)
no effect
For pre-test Alert scores no significant treatment effect or interaction with time was found.
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (pre-test)
n = 60
CGA | 60 | 65.69 (2.22) | 71.00 (2.20) | 68.39 (2.30)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (pre-test)
n = 60
CGA | 60 | 65.69 (2.22) | 71.00 (2.20) | 68.39 (2.30)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (pre-test)
n = 60
(PRE) | Green Blend | 60 | 69.20 (2.07) | 72.78 (2.01) | 68.30 (2.41)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (pre-test)
n = 60
(PRE) | Green Blend | 60 | 69.20 (2.07) | 72.78 (2.01) | 68.30 (2.41)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (pre-test)
n = 60
Bond-Lader Alert | Placebo | 60 | 69.61 (2.04) | 71.08(2.18) | 67.73 (2.06)
PMID 24349389 · one of two readings recorded this
Bond-Lader Alert (pre-test)
n = 60
Bond-Lader Alert | Placebo | 60 | 69.61 (2.04) | 71.08(2.18) | 67.73 (2.06)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (post-test)
no effect
No significant treatment effects or interactions with time were either pre or post-test.
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (post-test)
n = 60
CGA | 60 | 68.16 (2.56) | 67.40 (2.27) | 67.10 (2.50)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (post-test)
n = 60
CGA | 60 | 68.16 (2.56) | 67.40 (2.27) | 67.10 (2.50)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (post-test)
n = 60
(POST) | Green Blend | 60 | 67.70 (2.48) | 67.30 (2.23) | 66.75 (2.65)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (post-test)
n = 60
(POST) | Green Blend | 60 | 67.70 (2.48) | 67.30 (2.23) | 66.75 (2.65)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (post-test)
n = 60
Bond-Lader Calm | Placebo | 60 | 66.90 (2.41) | 67.23 (2.59) | 67.88 (2.42)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (post-test)
n = 60
Bond-Lader Calm | Placebo | 60 | 66.90 (2.41) | 67.23 (2.59) | 67.88 (2.42)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (pre-test)
no effect
No significant treatment effects or interactions with time were either pre or post-test.
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (pre-test)
n = 60
CGA | 60 | 74.88 (1.85) | 74.93 (2.02) | 72.59 (2.07)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (pre-test)
n = 60
CGA | 60 | 74.88 (1.85) | 74.93 (2.02) | 72.59 (2.07)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (pre-test)
n = 60
(PRE) | Green Blend | 60 | 75.07 (1.84) | 73.37 (1.98) | 72.20 (2.18)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (pre-test)
n = 60
(PRE) | Green Blend | 60 | 75.07 (1.84) | 73.37 (1.98) | 72.20 (2.18)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (pre-test)
n = 60
Bond-Lader Calm | Placebo | 60 | 75.29 (1.87) | 73.84 (2.09) | 71.66 (2.20)
PMID 24349389 · one of two readings recorded this
Bond-Lader Calm (pre-test)
n = 60
Bond-Lader Calm | Placebo | 60 | 75.29 (1.87) | 73.84 (2.09) | 71.66 (2.20)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
p = 0.07
However, for post-test Content scores a trend towards a main effect for treatment was found (F(2,59)=2.85,p=.07).
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
decreases, p = 0.07
Differences of Least Square Means revealed a trend towards contentedness being greater with placebo in comparison to CGA overall (t=2.33, p=.07, d=0.42).
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
unclear, p = 0.02
At 40 minutes Contentedness was found to be significantly greater with Placebo in comparison to placebo (t=2.86, p=.02, d=0.52).
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
n = 60
CGA | 60 | 74.58 (2.07) | 71.22 (2.36) | 72.22 (2.32)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
n = 60
CGA | 60 | 74.58 (2.07) | 71.22 (2.36) | 72.22 (2.32)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
n = 60
(POST) | Green Blend | 60 | 73.08 (2.20) | 72.35 (2.27) | 72.46 (2.33)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
n = 60
(POST) | Green Blend | 60 | 73.08 (2.20) | 72.35 (2.27) | 72.46 (2.33)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
n = 60
Bond-Lader Content | Placebo | 60 | 73.22 (2.16) | 73.00 (2.26) | 72.78 (2.27)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (post-test)
n = 60
Bond-Lader Content | Placebo | 60 | 73.22 (2.16) | 73.00 (2.26) | 72.78 (2.27)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (pre-test)
no effect
For pre-test Content scores no significant treatment effect or interaction with time was found.
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (pre-test)
n = 60
CGA | 60 | 78.93 (1.58) | 77.78 (1.87) | 77.85 (1.87)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (pre-test)
n = 60
CGA | 60 | 78.93 (1.58) | 77.78 (1.87) | 77.85 (1.87)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (pre-test)
n = 60
(PRE) | Green Blend | 60 | 78.20 (1.76) | 77.79 (1.81) | 76.69 (1.99)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (pre-test)
n = 60
(PRE) | Green Blend | 60 | 78.20 (1.76) | 77.79 (1.81) | 76.69 (1.99)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (pre-test)
n = 60
Bond-Lader Content | Placebo | 60 | 80.06 (1.52) | 79.25 (1.73) | 76.76 (2.00)
PMID 24349389 · one of two readings recorded this
Bond-Lader Content (pre-test)
n = 60
Bond-Lader Content | Placebo | 60 | 80.06 (1.52) | 79.25 (1.73) | 76.76 (2.00)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
p = 0.04
However, post-test a significant main effect for Treatment was revealed (F(2,59)=3.40,p=.04).
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
increases, p = 0.06
Differences of Least Square Means revealed that there was a trend towards Alertness being greater with decaffeinated green blend coffee in comparison to CGA (t=2.41,p=.05, d=0.44) and placebo (t=2.21,p=.06, d=0.40) overall.
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
increases, p = 0.02
At 120 minutes Alertness was found to be significantly greater with the green blend coffee in comparison to placebo (t=2.75, p=.02, d=0.50) and with green blend coffee in comparison to CGA (t=3.09, p=.009, d=0.56).
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
increases, p = 0.05
Differences of Least Square Means revealed that there was a trend towards Alertness being greater with decaffeinated green blend coffee in comparison to CGA (t=2.41,p=.05, d=0.44) and placebo (t=2.21,p=.06, d=0.40) overall.
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
increases, p = 0.009
At 120 minutes Alertness was found to be significantly greater with the green blend coffee in comparison to placebo (t=2.75, p=.02, d=0.50) and with green blend coffee in comparison to CGA (t=3.09, p=.009, d=0.56).
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
n = 60
CGA | 60 | 61.95 (2.78) | 55.95 (3.11) | 49.43 (2.80)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
n = 60
CGA | 60 | 61.95 (2.78) | 55.95 (3.11) | 49.43 (2.80)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
n = 60
(POST) | Green Blend | 60 | 60.20 (2.95) | 58.42 (2.95) | 56.65 (2.81)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
n = 60
(POST) | Green Blend | 60 | 60.20 (2.95) | 58.42 (2.95) | 56.65 (2.81)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
n = 60
CaffVAS Alertness | Placebo | 60 | 62.67 (2.76) | 57.12 (2.74) | 51.40 (2.84)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (post-test)
n = 60
CaffVAS Alertness | Placebo | 60 | 62.67 (2.76) | 57.12 (2.74) | 51.40 (2.84)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (pre-test)
no effect
Pre-test no significant treatment effects or interaction with time was found.
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (pre-test)
n = 60
CGA | 60 | 68.57 (2.67) | 68.25 (2.47) | 62.10 (2.92)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (pre-test)
n = 60
CGA | 60 | 68.57 (2.67) | 68.25 (2.47) | 62.10 (2.92)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (pre-test)
n = 60
(PRE) | Green Blend | 60 | 69.30 (2.49) | 69.88 (2.37) | 65.08 (2.81)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (pre-test)
n = 60
(PRE) | Green Blend | 60 | 69.30 (2.49) | 69.88 (2.37) | 65.08 (2.81)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (pre-test)
n = 60
CaffVAS Alertness | Placebo | 60 | 70.70 (2.25) | 68.67 (2.35) | 63.07 (2.37)
PMID 24349389 · one of two readings recorded this
CaffVAS Alertness (pre-test)
n = 60
CaffVAS Alertness | Placebo | 60 | 70.70 (2.25) | 68.67 (2.35) | 63.07 (2.37)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
p = 0.005
However, post-test a significant interaction between treatment and time was found (F(2,59)=5.93,p=.005).
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
decreases, p = 0.04
Differences of Least Square Means revealed that at 120 minutes Caff-VAS Headache scores were significantly lower with decaffeinated green blend coffee in comparison to placebo (t=2.51, p=.03, d=0.46) and with CGA in comparison to placebo (t=2.43, p=.04, d=0.44).
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
decreases, p = 0.03
Differences of Least Square Means revealed that at 120 minutes Caff-VAS Headache scores were significantly lower with decaffeinated green blend coffee in comparison to placebo (t=2.51, p=.03, d=0.46) and with CGA in comparison to placebo (t=2.43, p=.04, d=0.44).
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
n = 60
CGA | 60 | 17.18 (2.32) | 18.20 (2.61) | 17.18 (2.49)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
n = 60
CGA | 60 | 17.18 (2.32) | 18.20 (2.61) | 17.18 (2.49)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
n = 60
(POST) | Green Blend | 60 | 18.98 (3.09) | 17.68 (2.98) | 19.95 (3.35)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
n = 60
(POST) | Green Blend | 60 | 18.98 (3.09) | 17.68 (2.98) | 19.95 (3.35)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
n = 60
CaffVAS Headache | Placebo | 60 | 15.03 (2.34) | 16.38 (2.45) | 21.22 (2.98)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (post-test)
n = 60
CaffVAS Headache | Placebo | 60 | 15.03 (2.34) | 16.38 (2.45) | 21.22 (2.98)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (pre-test)
n = 60
CGA | 60 | 13.65 (2.06) | 15.82 (2.39) | 17.42 (2.70)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (pre-test)
n = 60
CGA | 60 | 13.65 (2.06) | 15.82 (2.39) | 17.42 (2.70)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (pre-test)
n = 60
(PRE) | Green Blend | 60 | 16.23 (2.63) | 16.02 (2.74) | 20.87 (3.27)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (pre-test)
n = 60
(PRE) | Green Blend | 60 | 16.23 (2.63) | 16.02 (2.74) | 20.87 (3.27)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (pre-test)
n = 60
CaffVAS Headache | Placebo | 60 | 13.07 (2.09) | 15.58 (2.44) | 19.00 (2.69)
PMID 24349389 · one of two readings recorded this
CaffVAS Headache (pre-test)
n = 60
CaffVAS Headache | Placebo | 60 | 13.07 (2.09) | 15.58 (2.44) | 19.00 (2.69)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (post-test)
p = 0.05
Post-test there was a trend towards an interaction between treatment and time (F(2,59)=3.13,p=.05), however no significant between-group differences were found with least square means.
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (post-test)
n = 60
CGA | 60 | 20.85 (2.44) | 19.30 (2.33) | 21.17 (2.68)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (post-test)
n = 60
CGA | 60 | 20.85 (2.44) | 19.30 (2.33) | 21.17 (2.68)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (post-test)
n = 60
(POST) | Green Blend | 60 | 20.37 (2.38) | 19.76 (2.49) | 20.47 (2.55)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (post-test)
n = 60
(POST) | Green Blend | 60 | 20.37 (2.38) | 19.76 (2.49) | 20.47 (2.55)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (post-test)
n = 60
CaffVAS Jittery | Placebo | 60 | 22.15 (2.62) | 21.90 (2.50) | 18.33 (2.15)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (post-test)
n = 60
CaffVAS Jittery | Placebo | 60 | 22.15 (2.62) | 21.90 (2.50) | 18.33 (2.15)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
p = 0.09
Pre-test there was a trend towards a main effect for Treatment (F(2,59)=2.46,p=.09).
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
decreases, p = 0.06
Differences of Least Square means revealed a trend towards decreased Jitteriness with decaffeinated green blend coffee in comparison to placebo at 40 minutes (t=2.24,p=.06, d=0.41) and with CGA in comparison to placebo at 40 minutes (t=2.20,p=.06, d=0.40).
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
decreases, p = 0.06
Differences of Least Square means revealed a trend towards decreased Jitteriness with decaffeinated green blend coffee in comparison to placebo at 40 minutes (t=2.24,p=.06, d=0.41) and with CGA in comparison to placebo at 40 minutes (t=2.20,p=.06, d=0.40).
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
n = 60
CGA | 60 | 18.73 (2.26) | 16.35 (1.94) | 18.10 (2.12)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
n = 60
CGA | 60 | 18.73 (2.26) | 16.35 (1.94) | 18.10 (2.12)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
n = 60
(PRE) | Green Blend | 60 | 18.97 (2.18) | 16.32 (1.79) | 17.10 (2.06)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
n = 60
(PRE) | Green Blend | 60 | 18.97 (2.18) | 16.32 (1.79) | 17.10 (2.06)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
n = 60
CaffVAS Jittery | Placebo | 60 | 14.45 (1.57) | 18.97 (2.24) | 17.70 (2.14)
PMID 24349389 · one of two readings recorded this
CaffVAS Jittery (pre-test)
n = 60
CaffVAS Jittery | Placebo | 60 | 14.45 (1.57) | 18.97 (2.24) | 17.70 (2.14)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (post-test)
no effect
No significant treatment effect or treatment by time interaction was found either pre or post-test.
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (post-test)
n = 60
CGA | 60 | 37.22 (3.06) | 45.62 (3.10) | 53.55 (3.10)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (post-test)
n = 60
CGA | 60 | 37.22 (3.06) | 45.62 (3.10) | 53.55 (3.10)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (post-test)
n = 60
(POST) | Green Blend | 60 | 38.22 (3.14) | 45.31 (3.30) | 48.67 (3.29)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (post-test)
n = 60
(POST) | Green Blend | 60 | 38.22 (3.14) | 45.31 (3.30) | 48.67 (3.29)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (post-test)
n = 60
CaffVAS Mental Fatigue | Placebo | 60 | 37.58 (3.11) | 44.77 (3.11) | 52.02 (3.23)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (post-test)
n = 60
CaffVAS Mental Fatigue | Placebo | 60 | 37.58 (3.11) | 44.77 (3.11) | 52.02 (3.23)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (pre-test)
no effect
No significant treatment effect or treatment by time interaction was found either pre or post-test.
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (pre-test)
n = 60
CGA | 60 | 22.75 (2.67) | 29.73 (2.76) | 37.77 (3.33)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (pre-test)
n = 60
CGA | 60 | 22.75 (2.67) | 29.73 (2.76) | 37.77 (3.33)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (pre-test)
n = 60
(PRE) | Green Blend | 60 | 21.73 (2.48) | 32.62 (3.03) | 37.42 (3.18)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (pre-test)
n = 60
(PRE) | Green Blend | 60 | 21.73 (2.48) | 32.62 (3.03) | 37.42 (3.18)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (pre-test)
n = 60
CaffVAS Mental Fatigue | Placebo | 60 | 21.65 (2.21) | 31.72 (2.79) | 37.08 (2.69)
PMID 24349389 · one of two readings recorded this
CaffVAS Mental Fatigue (pre-test)
n = 60
CaffVAS Mental Fatigue | Placebo | 60 | 21.65 (2.21) | 31.72 (2.79) | 37.08 (2.69)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (post-test)
no effect
No significant main effects or treatment by time interactions were either pre or post-test.
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (post-test)
n = 60
CGA | 60 | 74.97 (2.46) | 72.78 (2.45) | 71.68 (2.56)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (post-test)
n = 60
CGA | 60 | 74.97 (2.46) | 72.78 (2.45) | 71.68 (2.56)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (post-test)
n = 60
(POST) | Green Blend | 60 | 74.35 (2.32) | 71.97 (2.74) | 69.28 (2.96)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (post-test)
n = 60
(POST) | Green Blend | 60 | 74.35 (2.32) | 71.97 (2.74) | 69.28 (2.96)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (post-test)
n = 60
CaffVAS Overall Mood | Placebo | 60 | 73.12 (2.76) | 73.20 (2.54) | 72.62 (2.63)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (post-test)
n = 60
CaffVAS Overall Mood | Placebo | 60 | 73.12 (2.76) | 73.20 (2.54) | 72.62 (2.63)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (pre-test)
no effect
No significant main effects or treatment by time interactions were either pre or post-test.
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (pre-test)
n = 60
CGA | 60 | 79.35 (2.36) | 76.37 (2.58) | 75.80 (2.48)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (pre-test)
n = 60
CGA | 60 | 79.35 (2.36) | 76.37 (2.58) | 75.80 (2.48)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (pre-test)
n = 60
(PRE) | Green Blend | 60 | 79.42 (1.87) | 76.53 (2.47) | 74.93 (2.40)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (pre-test)
n = 60
(PRE) | Green Blend | 60 | 79.42 (1.87) | 76.53 (2.47) | 74.93 (2.40)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (pre-test)
n = 60
CaffVAS Overall Mood | Placebo | 60 | 82.10 (1.84) | 77.27 (2.26) | 77.05 (2.04)
PMID 24349389 · one of two readings recorded this
CaffVAS Overall Mood (pre-test)
n = 60
CaffVAS Overall Mood | Placebo | 60 | 82.10 (1.84) | 77.27 (2.26) | 77.05 (2.04)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (post-test)
no effect
No significant treatment effects or interaction with time were found either pre or post-test.
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (post-test)
n = 60
CGA | 60 | 65.33 (2.68) | 60.40 (3.25) | 59.65 (2.96)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (post-test)
n = 60
CGA | 60 | 65.33 (2.68) | 60.40 (3.25) | 59.65 (2.96)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (post-test)
n = 60
(POST) | Green Blend | 60 | 65.22 (2.75) | 62.27 (2.91) | 65.73 (2.87)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (post-test)
n = 60
(POST) | Green Blend | 60 | 65.22 (2.75) | 62.27 (2.91) | 65.73 (2.87)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (post-test)
n = 60
CaffVAS Relaxation | Placebo | 60 | 64.02 (2.77) | 63.23 (2.95) | 63.27 (2.64)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (post-test)
n = 60
CaffVAS Relaxation | Placebo | 60 | 64.02 (2.77) | 63.23 (2.95) | 63.27 (2.64)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (pre- or post-test not stated)
increases, p = 0.02
However differences of Least Square Means revealed that at 120 minutes Relaxation was significantly greater with decaffeinated green blend coffee in comparison to CGA (t=2.75,p=.02, d=0.50).
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (pre-test)
no effect
No significant treatment effects or interaction with time were found either pre or post-test.
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (pre-test)
n = 60
CGA | 60 | 73.05 (2.33) | 71.65 (2.44) | 67.33 (2.62)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (pre-test)
n = 60
CGA | 60 | 73.05 (2.33) | 71.65 (2.44) | 67.33 (2.62)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (pre-test)
n = 60
(PRE) | Green Blend | 60 | 72.62 (2.47) | 70.55 (2.42) | 68.07 (2.63)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (pre-test)
n = 60
(PRE) | Green Blend | 60 | 72.62 (2.47) | 70.55 (2.42) | 68.07 (2.63)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (pre-test)
n = 60
CaffVAS Relaxation | Placebo | 60 | 71.42 (2.58) | 72.95 (2.17) | 70.30 (2.19)
PMID 24349389 · one of two readings recorded this
CaffVAS Relaxation (pre-test)
n = 60
CaffVAS Relaxation | Placebo | 60 | 71.42 (2.58) | 72.95 (2.17) | 70.30 (2.19)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (post-test)
no effect
Post-test no significant treatment effect or treatment by time interaction was found.
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (post-test)
n = 60
CGA | 60 | 30.88 (2.64) | 29.15 (2.62) | 30.38 (2.77)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (post-test)
n = 60
CGA | 60 | 30.88 (2.64) | 29.15 (2.62) | 30.38 (2.77)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (post-test)
n = 60
(POST) | Green Blend | 60 | 27.23 (2.54) | 28.44 (3.06) | 30.82 (3.26)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (post-test)
n = 60
(POST) | Green Blend | 60 | 27.23 (2.54) | 28.44 (3.06) | 30.82 (3.26)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (post-test)
n = 60
CaffVAS Tension | Placebo | 60 | 29.85 (2.79) | 29.37 (2.84) | 31.27 (3.00)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (post-test)
n = 60
CaffVAS Tension | Placebo | 60 | 29.85 (2.79) | 29.37 (2.84) | 31.27 (3.00)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (pre-test)
p = 0.06
Pre-test there was a trend towards an interaction between treatment and time (F(2,59)=3.03,p=.06).
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (pre-test)
decreases, p = 0.07
Differences of Least Square Means revealed that at 120 minutes there was a trend towards Caff-VAS Tense scores being lower with decaffeinated green blend coffee in comparison to placebo (t=2.36,p=.07, d=0.43).
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (pre-test)
n = 60
CGA | 60 | 19.85 (2.04) | 21.42 (2.10) | 24.78 (2.47)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (pre-test)
n = 60
CGA | 60 | 19.85 (2.04) | 21.42 (2.10) | 24.78 (2.47)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (pre-test)
n = 60
(PRE) | Green Blend | 60 | 20.78 (2.14) | 22.33 (2.46) | 22.47 (2.36)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (pre-test)
n = 60
(PRE) | Green Blend | 60 | 20.78 (2.14) | 22.33 (2.46) | 22.47 (2.36)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (pre-test)
n = 60
CaffVAS Tension | Placebo | 60 | 19.85 (1.98) | 20.97 (2.12) | 26.03 (2.41)
PMID 24349389 · one of two readings recorded this
CaffVAS Tension (pre-test)
n = 60
CaffVAS Tension | Placebo | 60 | 19.85 (1.98) | 20.97 (2.12) | 26.03 (2.41)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (post-test)
p = 0.03
However, post-test a significant interaction between treatment and time was found (F(2,59)=3.79,p=.03).
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (post-test)
decreases, p = 0.04
Differences of Least Square Means revealed that at 40 minutes Tiredness was significantly lower with CGA in comparison to placebo (t=2.53,p=.04, d=0.46).
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (post-test)
n = 60
CGA | 60 | 34.95 (2.82) | 39.80 (2.76) | 50.45 (2.81)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (post-test)
n = 60
CGA | 60 | 34.95 (2.82) | 39.80 (2.76) | 50.45 (2.81)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (post-test)
n = 60
(POST) | Green Blend | 60 | 35.98 (2.81) | 44.39 (3.23) | 46.63 (3.00)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (post-test)
n = 60
(POST) | Green Blend | 60 | 35.98 (2.81) | 44.39 (3.23) | 46.63 (3.00)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (post-test)
n = 60
CaffVAS Tiredness | Placebo | 60 | 38.38 (2.89) | 47.13 (3.02) | 49.95 (2.83)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (post-test)
n = 60
CaffVAS Tiredness | Placebo | 60 | 38.38 (2.89) | 47.13 (3.02) | 49.95 (2.83)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (pre-test)
n = 60
CGA | 60 | 29.62 (2.93) | 33.33 (2.74) | 36.97 (2.69)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (pre-test)
n = 60
CGA | 60 | 29.62 (2.93) | 33.33 (2.74) | 36.97 (2.69)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (pre-test)
n = 60
(PRE) | Green Blend | 60 | 26.75 (2.60) | 32.92 (2.71) | 36.25 (2.67)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (pre-test)
n = 60
(PRE) | Green Blend | 60 | 26.75 (2.60) | 32.92 (2.71) | 36.25 (2.67)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (pre-test)
n = 60
CaffVAS Tiredness | Placebo | 60 | 26.50 (2.27) | 34.03 (2.84) | 40.45 (2.62)
PMID 24349389 · one of two readings recorded this
CaffVAS Tiredness (pre-test)
n = 60
CaffVAS Tiredness | Placebo | 60 | 26.50 (2.27) | 34.03 (2.84) | 40.45 (2.62)
PMID 24349389 · one of two readings recorded this
inspection time
increases, p = 0.08
No significant treatment effect or interaction with time was found, although differences of least square means revealed that at 120 minutes post-dose IT was significantly slower with CGA consumption in comparison to placebo (t=-2.26, p=.08, d=0.41).
PMID 24349389 · one of two readings recorded this
inspection time
n = 60
CGA | 60 | 89.00 (5.08) | 99.13 (7.04) | 121.0 (15.41)
PMID 24349389 · one of two readings recorded this
inspection time
n = 60
CGA | 60 | 89.00 (5.08) | 99.13 (7.04) | 121.0 (15.41)
PMID 24349389 · one of two readings recorded this
inspection time
n = 60
Green Blend | 60 | 92.92 (5.14) | 96.04 (4.72) | 105.2 (7.37)
PMID 24349389 · one of two readings recorded this
inspection time
n = 60
Green Blend | 60 | 92.92 (5.14) | 96.04 (4.72) | 105.2 (7.37)
PMID 24349389 · one of two readings recorded this
inspection time
n = 60
Inspection Time (ms) | Placebo | 60 | 101.5 (9.35) | 110.2 (10.77) | 106.8 (11.13)
PMID 24349389 · one of two readings recorded this
inspection time
n = 60
Inspection Time (ms) | Placebo | 60 | 101.5 (9.35) | 110.2 (10.77) | 106.8 (11.13)
PMID 24349389 · one of two readings recorded this
Jensen 1-choice decision time
n = 60
CGA | 60 | 331.4 (7.09) | 334.5 (7.55) | 340.6 (8.42)
PMID 24349389 · one of two readings recorded this